Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Longeveron	Verseon	Helix BioPharma	ImmunoPrecise Antibodies	Circassia Group
Symbol	NASDAQ:LGVN	LON:VSN	TSE:HBP	CVE:IPA	LON:CIR
Price Information
Current Price	$5.30	GBX 74	C$0.92	C$9.50	GBX 34.50
52 Week Range	N/A	N/A	N/A	N/A	N/A
MarketRank™
Overall Score	0.0	0.5	0.5	0.4	0.9
Analysis Score	0.0	0.0	0.0	0.0	0.0
Community Score	0.0	2.4	2.3	1.9	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	1.7
Earnings & Valuation Score	0.0	0.0	0.0	0.0	0.0
Analyst Ratings
Consensus Recommendation	N/A	N/A	N/A	N/A	N/A
Consensus Price Target	N/A	N/A	N/A	N/A	N/A
% Upside from Price Target	N/A	N/A	N/A	N/A	N/A
Trade Information
Market Cap	$100.47 million	£127.41 million	C$129.84 million	C$123.03 million	£144.28 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	833,586	75,334	42,133	58,771	969,743
Sales & Book Value
Annual Revenue	N/A	N/A	N/A	C$17.18 million	£23.90 million
Price / Sales	N/A	N/A	N/A	10.55	6.04
Cashflow	N/A	GBX 11.19 per share	C$0.03 per share	C$0.83 per share	GBX 2.11 per share
Price / Cash	N/A	6.61	31.03	11.43	16.32
Book Value	N/A	GBX 21 per share	C$0.03 per share	C$1.88 per share	GBX 16.60 per share
Price / Book	N/A	N/A	N/A	5.04	0.02
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	N/A	GBX (14.30)	C($0.06)	C($0.21)	GBX (8.80)
Trailing P/E Ratio	0.00	N/A	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	74.84%	1.78%	11.37%	2.42%
Current Ratio	N/A	3.36%	3.95%	3.39%	1.11%
Quick Ratio	N/A	3.09%	3.63%	2.88%	0.89%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	12	N/A	10	N/A	162
Shares Outstanding	18.96 million	151.67 million	141.13 million	19.08 million	418.20 million
Next Earnings Date	8/13/2021 (Estimated)	N/A	7/29/2021 (Estimated)	8/27/2021 (Estimated)	6/14/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Allergy Immunotherapy Market Analyzed by Top 5 Key Players by Size, revenue and Forecasts To 2027 openpr.com - May 10 at 2:05 PM
	Circassia Pharmaceuticals plc (CIRCI) uk.investing.com - April 29 at 6:40 PM
	Circassia Group (LON:CIR) Trading Up 5.6% americanbankingnews.com - April 28 at 12:22 AM
	Circassia Group Plc - Annual Report and Notice of AGM proactiveinvestors.co.uk - April 21 at 8:49 AM
	Circassia Group Plc - Director/PDMR Shareholding proactiveinvestors.co.uk - April 10 at 1:24 PM
	How Much Did Circassia Group's(LON:CIR) Shareholders Earn From Share Price Movements Over The Last Five Years? finance.yahoo.com - April 5 at 8:15 AM
	Global Allergy Immunotherapies Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts marketwatch.com - March 24 at 3:47 PM
	Circassia Group enters subscription agreements to raise £5 million stockmarketwire.com - March 24 at 10:46 AM
	Circassia narrows annual losses on cost cuts; sees early signs of recovery stockmarketwire.com - March 24 at 5:45 AM
	Circassia Group Plc - Subscription to raise £5 million proactiveinvestors.co.uk - March 24 at 5:45 AM
	Drone strike on Riyadh oil refinery claimed by Houthis causes fire in.finance.yahoo.com - March 21 at 2:03 PM
	Rockefeller Capital Management Continues Growth of Private Wealth Business, Announces Inaugural Team in Ohio sg.finance.yahoo.com - March 21 at 2:03 PM
	Circassia Group Plc (82C.F) ca.finance.yahoo.com - March 17 at 2:30 PM
	Allergy Immunotherapy Market Analysis by Key Players & Industry Size 2027 openpr.com - March 10 at 1:21 PM
	Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care nature.com - February 14 at 12:54 AM
	Circassia Group Plc - PDMR Dealing - Transfer for Nil Consideration proactiveinvestors.co.uk - February 4 at 12:43 PM
	How Much Of Circassia Group Plc (LON:CIR) Do Insiders Own? finance.yahoo.com - February 4 at 12:43 PM
	Circassia Group Plc - Total Voting Rights proactiveinvestors.co.uk - January 31 at 2:17 AM
	Circassia Group Plc - Trading Update proactiveinvestors.co.uk - January 12 at 2:53 PM
	Circassia's Niox Revenue Dips As Pandemic Restricts Routine Testing lse.co.uk - January 12 at 9:48 AM
	Circassia lowers earnings breakeven point after restructuring; annual revenue falls stockmarketwire.com - January 12 at 4:47 AM
	Circassia Group PLC barrons.com - December 31 at 12:53 AM
	Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H2 2020 - Therapeutic Analysis Report Featuring 50+ Companies - ResearchAndMarkets.com morningstar.com - November 24 at 7:06 PM
	Eurasia Mining PLC - Price Monitoring Extension proactiveinvestors.co.uk - October 4 at 5:31 PM
	Eurasia Mining PLC - Second Price Monitoring Extn proactiveinvestors.co.uk - October 4 at 7:18 AM

Date	Company	Brokerage	Action
6/16/2020	Circassia Group	Peel Hunt	Reiterated Rating
6/16/2020	Circassia Group	FinnCap	Reiterated Rating
10/15/2019	Circassia Group	Peel Hunt	Reiterated Rating

(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources